Table 2.
Characteristic | n (%) | SF-36 PCS, | SF-36 MCS, |
---|---|---|---|
mean (SD) | mean (SD) | ||
Months since end of treatment * | P = 0.709 | P = 0.091 | |
≤12 | 66 (20.4) | 43.84 (11.04) | 46.43 (12.59) |
13-24 | 181 (56.1) | 45.12 (10.43) | 50 (11.49) |
25+ | 76 (23.5) | 44.71 (11.27) | 49.82 (11) |
Surgery received | P = 0.941 | P = 0.009 | |
Lumpectomy | 201 (60.7) | 44.81 (11.14) | 50.32 (10.88) |
Mastectomy | 98 (29.6) | 44.72 (10.01) | 48.94 (11.84) |
Bilateral mastectomy | 32 (9.7) | 44.11 (10.13) | 43.59 (14.11) |
Chemotherapy | P = 0.851 | P = 0.004 | |
No | 158 (47.7) | 44.83 (10.55) | 51.17 (11.59) |
Yes | 173 (52.3) | 44.61 (10.86) | 47.52 (11.43) |
Radiation | P = 0.906 | P = 0.063 | |
No | 97 (29.3) | 44.61 (10.16) | 47.4 (13.4) |
Yes | 234 (70.7) | 44.76 (10.93) | 50.02 (10.78) |
Hormonal therapy a | P = 0.496 | P = 0.446 | |
No | 113 (34.1) | 44.16 (11.15) | 48.59 (13.37) |
Yes | 218 (65.9) | 45.01 (10.47) | 49.62 (10.64) |
Treatment mix | P = 0.184 | P = 0.002 | |
Surgery only | 50 (15.1) | 46.68 (9.7) | 50.96 (12.71) |
Surgery, chemotherapy | 47 (14.2) | 42.4 (10.28) | 43.61 (13.21) |
Surgery, radiation | 108 (32.6) | 44 (10.86) | 51.27 (11.11) |
Surgery, chemo, radiation | 126 (38.1) | 45.42 (10.99) | 48.95 (10.41) |
Notes: P-values from ANOVA tests; * Counts < 331 due to missing responses;
aOn hormonal treatment at the time the data were collected.